SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 114 filers reported holding SUTRO BIOPHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $596,000 | -36.6% | 114,437 | +0.1% | 0.02% | -22.7% |
Q1 2022 | $940,000 | -50.6% | 114,312 | -10.6% | 0.02% | -45.0% |
Q4 2021 | $1,904,000 | -23.5% | 127,925 | -2.9% | 0.04% | -28.6% |
Q3 2021 | $2,490,000 | +1.3% | 131,792 | -0.3% | 0.06% | +5.7% |
Q2 2021 | $2,457,000 | -23.6% | 132,174 | -6.5% | 0.05% | -18.5% |
Q1 2021 | $3,216,000 | -1.4% | 141,290 | -6.0% | 0.06% | -12.2% |
Q4 2020 | $3,263,000 | – | 150,283 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 1,824,542 | $39,611,000 | 19.08% |
Samsara BioCapital, LLC | 1,675,579 | $36,377,000 | 3.66% |
SILVERARC CAPITAL MANAGEMENT, LLC | 185,000 | $4,016,000 | 2.33% |
Affinity Asset Advisors, LLC | 200,000 | $4,342,000 | 2.30% |
Altium Capital Management LP | 276,719 | $6,008,000 | 2.24% |
FRAZIER MANAGEMENT LLC | 1,001,421 | $21,741,000 | 1.67% |
BVF INC/IL | 1,854,162 | $40,254,000 | 1.58% |
Asymmetry Capital Management, L.P. | 157,583 | $3,421,000 | 1.56% |
Parkman Healthcare Partners LLC | 266,645 | $5,789,000 | 1.48% |
AJU IB Investment Co., Ltd. | 175,000 | $3,799,000 | 1.44% |